Prognosis of acutely ruptured intracranial aneurysms

Study on Prognosis of Acutely Ruptured Intracranial Aneurysms

Haaglanden Medical Centre · NCT05851989

This study is testing whether surgical clipping or endovascular coiling is better for helping patients recover after a brain aneurysm rupture.

Quick facts

Study typeObservational
Enrollment880 (estimated)
Ages18 Years and up
SexAll
SponsorHaaglanden Medical Centre (other)
Locations6 sites (Amsterdam and 5 other locations)
Trial IDNCT05851989 on ClinicalTrials.gov

What this trial studies

The SPARTA study is a prospective multicenter observational trial conducted in the Netherlands aimed at identifying the best clinical care for patients with aneurysmal subarachnoid hemorrhage. It will compare the effectiveness of surgical clipping versus endovascular coiling treatments on patient outcomes one year after the onset of symptoms. Additionally, the study will evaluate long-term functional outcomes, complications, cost-effectiveness, and the prognostic value of radiological imaging. Patients will be followed for up to 10 years to gather comprehensive data on their recovery and treatment efficacy.

Who should consider this trial

Good fit: Ideal candidates for this study are adults aged 18 and over who have a confirmed diagnosis of subarachnoid hemorrhage due to an intracranial aneurysm.

Not a fit: Patients with subarachnoid hemorrhage of perimesencephalic or post-traumatic origin, or those without a diagnosed intracranial aneurysm after six months, may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide insights into the most effective treatment options for patients with ruptured intracranial aneurysms, potentially improving patient outcomes.

How similar studies have performed: Previous studies have explored treatment options for ruptured intracranial aneurysms, but this study aims to provide more definitive comparisons and insights, making it a valuable addition to existing research.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Confirmed diagnosis of subarachnoid haemorrhage on CT-scan or lumbar puncture (in the presence of a negative CT-scan)
* Intracranial aneurysm proven within 6 months to be the cause of subarachnoid haemorrhage
* Age 18 years or over at presentation.
* Written informed consent

Exclusion Criteria:

* Subarachnoid haemorrhage deemed most likely of 'perimesencephalic' origin after consideration of history, clinical examination and radiological findings (including angiographic imaging)
* Subarachnoid haemorrhage deemed most likely of post-traumatic origin after consideration of history, clinical examination and radiological findings (including angiographic imaging)
* Diagnosis of intracerebral arteriovenous malformations or dural arteriovenous fistula.
* No diagnosis of intracranial aneurysm at 6 months after onset of symptoms.
* Not mastering the Dutch language

Where this trial is running

Amsterdam and 5 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Aneurysmal Subarachnoid Hemorrhage, Endovascular Procedures, Craniotomy, Patient Outcome Assessment, Treatment Outcome, Aneurysmal subarachnoid hemorrhage, Clipping, Neurosurgery

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.